Abstract:Background: Individuals with 22q11.2 Deletion Syndrome (22q11.2 DS) are a specific high-risk group for developing schizophrenia (SZ), schizoaffective disorder (SAD) and autism spectrum disorders (ASD). Several genes in the deleted region have been implicated in the development of SZ, e.g., PRODH and DGCR8. However, the mechanistic connection between these genes and the neuropsychiatric phenotype remains unclear. To elucidate the molecular consequences of 22q11.2 deletion in early neural development, we carried out RNA-seq analysis to investigate gene expression in early differentiating human neurons derived from induced pluripotent stem cells (iPSCs) of 22q11.2 DS SZ and SAD patients. Methods: Eight cases (ten iPSC-neuron samples in total including duplicate clones) and seven controls (nine in total including duplicate clones) were subjected to RNA sequencing. Using a systems level analysis, differentially expressed genes/gene-modules and pathway of interests were identified. Lastly, we related our findings from in vitro neuronal cultures to brain development by mapping differentially expressed genes to BrainSpan transcriptomes. Results: We observed ~2-fold reduction in expression of almost all genes in the 22q11.2 region in SZ (37 genes reached p-value < 0.05, 36 of which reached a false discovery rate < 0.05). Outside of the deleted region, 745 genes showed significant differences in expression between SZ and control neurons (p < 0.05). Function enrichment and network analysis of the differentially expressed genes uncovered converging evidence on abnormal expression in key functional pathways, such as apoptosis, cell cycle and survival, and MAPK signaling in the SZ and SAD samples. By leveraging transcriptome profiles of normal human brain tissues across human development into adulthood, we showed that the differentially expressed genes converge on a sub-network mediated by CDC45 and the cell cycle, which would be disrupted by the 22q11.2 deletion during embryonic brain development, and another sub-network modulated by PRODH, which could contribute to disruption of brain function during adolescence. Conclusions: This study has provided evidence for disruption of potential molecular events in SZ patient with 22q11.2 deletion and related our findings from in vitro neuronal cultures to functional perturbations that can occur during brain development in SZ.

Evidence for a Potential Common Gene Network of Smith-Magenis and Potocki-Lupski Syndromes, DAND (DEAF1-Associated Neurodevelopmental Disorder) and ZEB1-Associated Neurodevelopment Disorder

Evidence for a Potential Common Gene Network of Smith-Magenis&nbsp;and Potocki-Lupski Syndromes,&nbsp;DAND (DEAF1-Associated Neurodevelopmental Disorder)&nbsp;and&nbsp;ZEB1-Associated Neurodevelopment Disorder

Functional Analysis of Novel DEAF1 Variants Identified Through Clinical Exome Sequencing Expands DEAF1-associated Neurodevelopmental Disorder (DAND) Phenotype.

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics

Identification of a molecular network regulated by multiple ASD high risk genes

Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder

Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 ( RAI1 ) in human brain

Disruptive Variants of CSDE1 Associate with Autism and Interfere with Neuronal Development and Synaptic Transmission

Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome

Deleterious ZNRF3 germline variants cause neurodevelopmental disorders with mirror brain phenotypes via domain-specific effects on Wnt/β-catenin signaling

Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion

A Convergent Molecular Network Underlying Autism and Congenital Heart Disease

Shared genetic architecture and causal pathways between attention deficit hyperactivity disorder and restless legs syndrome

ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations

Epigenomic and phenotypic characterization of DEGCAGS syndrome

Wnt signaling networks in autism spectrum disorder and intellectual disability

Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome

Convergent Transcriptomic Evidence Reveals the Dysfunctional Quantitative Mechanism of Synaptic Plasticity Control in ASD

Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development

Synaptic function and sensory processing in ZDHHC9-associated neurodevelopmental disorder: a mechanistic account